| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/20/2002 | WO2001064755A3 Isoxazole gegen virale erkrankungen |
| 06/20/2002 | WO2001056590A3 Utilization of protein kinase inhibitor alpha |
| 06/20/2002 | WO2001054771A3 Method for using potassium channel agonists for delivering a medicant to an abnormal brain region and/or a malignant tumor |
| 06/20/2002 | WO2001052837A3 Use of at least a fatty ester for preparing a composition designed to inhibit 5-$g(a)-reductase activity, in pharmacology, in particular dermatology, in cosmetics and as food additive |
| 06/20/2002 | WO2001047528A3 Novel glycosidase inhibitors and their pharmacological uses, in particular for treating diabetes |
| 06/20/2002 | WO2001044445A8 Human lyases and associated proteins |
| 06/20/2002 | WO2001037818A3 Medicament and combination of compatible medicaments |
| 06/20/2002 | WO2001032693A3 Trp-protein-related mtr1 protein and dna sequence coding therefor |
| 06/20/2002 | WO2001003688A3 Treatment of cyclooxygenase-2 mediated disorders using conjugated fatty acid compounds |
| 06/20/2002 | WO2000077233A9 Complement-resistant non-mammalian dna viruses and uses thereof |
| 06/20/2002 | WO2000067734A3 Use of phthalazine derivatives |
| 06/20/2002 | WO2000052210A9 Methods for targeting rna molecules |
| 06/20/2002 | US20020077486 Platelet ADP receptor inhibitors |
| 06/20/2002 | US20020077482 Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 06/20/2002 | US20020077465 Nuceotide sequences coding enzymatic polypeptide for use in the treatment and prevention of inflammation, cancer, muuscle disorders and thrombosis |
| 06/20/2002 | US20020077362 Higher unsaturated fatty acid composition |
| 06/20/2002 | US20020077361 Can be administered with conventional drugs to treat psychiatric or central nervous disorders to improve their efficacy or reduce their side effects |
| 06/20/2002 | US20020077357 For therapy of autoimmune disease |
| 06/20/2002 | US20020077351 For therapy and prophylaxis of diseases such as cachexia attributed to cancer or infections, rheumatoid arthritis, inflammatory diseases, osteoarthritis, systemic lupus erythematosus, rejection during bone marrow transplantation |
| 06/20/2002 | US20020077344 For therapy and prophylaxis of high blood pressure, cardiac hypertrophy, cardiac insufficiency, coronary heart diseases such as angina pectoris, cardiac infarct, vascular restenosis after angioplasty, cardiomyopathies, endothelial dysfunction |
| 06/20/2002 | US20020077339 Chemokine receptor binding heterocyclic compounds |
| 06/20/2002 | US20020077338 HIV protease inhibitors |
| 06/20/2002 | US20020077337 Chemical compounds |
| 06/20/2002 | US20020077335 For therapy of asthma, chronic obstructive pulmonary disease, airway hyperreactivity, skin disorders and itch (for example, atopic dermatitis and cutaneous wheal and flare), neurogenic inflammation and Parkinson's disease, psychosis |
| 06/20/2002 | US20020077333 For therapy inflammation, inflammatory diseases, immunologic diseases and other diseases mediated by tumor necrosis factor-alpha (TNF-alpha) and/or interleukin 6 or 10 and/or enzyme cyclooxygenase-2 (COX-2) |
| 06/20/2002 | US20020077332 Zolpidem hemitartrate |
| 06/20/2002 | US20020077330 For therapy of tumoral diseases, diseases of the lungs and respiratory tract |
| 06/20/2002 | US20020077329 EP4 receptor inhibitors to treat rheumatoid arthritis |
| 06/20/2002 | US20020077319 Combination of GABA agonists and aldose reductase inhibitors |
| 06/20/2002 | US20020077318 Substituted azepino[4,5b] indoline derivatives |
| 06/20/2002 | US20020077316 For therapy and prophylaxis of cardiovascular disease, dyslipidemia; dyslipoproteinemia; disorder of glucose metabolism; Alzheimer's Disease; Syndrome X; peroxisome proliferator activated receptor-associated disorder |
| 06/20/2002 | US20020077296 High-throughput screening method |
| 06/20/2002 | US20020077295 For therapy of cranial or cerebral trauma, spinal cord injury, stroke or a demyelinating disease |
| 06/20/2002 | US20020077281 Fracture healing using pthrp analogs |
| 06/20/2002 | US20020077277 Method of treating chronic ulcers |
| 06/20/2002 | US20020077274 Administering therapeutically effective amount of a compound that inhibits cGMP-specific phosphodiesterase (PDE5) for therapy of Parkinson's disease |
| 06/20/2002 | US20020077273 Methods of using agents that modulate bone formation and inhibit adipogenesis |
| 06/20/2002 | US20020076798 Liver-specific gene expression cassettes, and methods of use |
| 06/20/2002 | US20020076795 Novel TRF1 binding protein, methods of use thereof |
| 06/20/2002 | US20020076793 Interleukin-1 beta converting enzyme like apoptosis protease-3 and 4 |
| 06/20/2002 | US20020076783 Plants and plants cells expressing histidine tagged intimin |
| 06/20/2002 | US20020076777 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 06/20/2002 | US20020076755 G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same |
| 06/20/2002 | US20020076750 Peptide for use as tools in human therapeutics and diagnostics |
| 06/20/2002 | US20020076705 Nucleotide sequences which code preferential polypeptide; for use in the detection, treatment, and prevention of alzheimer's, parkinson's, huntington's, Tourette Syndrome, meningitis, encephalitis, congenital disorders and brain |
| 06/20/2002 | US20020076702 Evaluating prostaglandin response to preferential modulators; obtain sample, incubate with modulator, compare profile with control, determine if human had prostaglandin response to moduator based on differences in control and sample profiles |
| 06/20/2002 | US20020076453 Angiotensin I-converting enzyme inhibitory substance |
| 06/20/2002 | US20020076446 Novel medicinal herbal composition for treating liver diseases and HIV |
| 06/20/2002 | US20020076421 Oral liquid mucoadhesive compositions |
| 06/20/2002 | US20020076418 Use of strains of parapoxvirus ovis against organ fibrosis |
| 06/20/2002 | US20020076416 Chimeric peptide immunogens |
| 06/20/2002 | US20020076413 Administering fragments, conformations, biological equivalent, or derivatives of antithrombin III; anticancer agents |
| 06/20/2002 | DE10063173A1 Harnstoff- und Urethanderivate Urea and urethane |
| 06/20/2002 | DE10063111A1 Replikationsassay zur Auffindung antiviraler Substanzen Replication assay for the detection of antiviral substances |
| 06/20/2002 | DE10062712A1 Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden New pharmaceutical compositions based on anticholinergics and corticosteroids |
| 06/20/2002 | DE10062401A1 Verwendung von Folsäure und/oder deren Derivaten zur Herstellung kosmetischer oder dermatologischer Zubereitungen zur Prophylaxe von Schäden an der hauteigenen DNA und/oder zur Reparatur bereits eingetretener Schäden an der hauteigenen DNA Use of folic acid and / or derivatives thereof for producing cosmetic or dermatological preparations for the prevention of damage to the skin's DNA and / or repair of already occurred damage to the skin's DNA |
| 06/20/2002 | DE10060809A1 Substituierte Anthranilsäuren, ihre Verwendung als Medikament oder Diagnostikum, sowie sie enthaltendes Medikament, sowie ein pharmazeutisches Kombinationspräparat mit einem Natrium/Wasserstoff-Austausch (NHE)-Blocker Substituted anthranilic acids, their use as a medicament or diagnostic, and she containing drug, as well as a pharmaceutical combination preparation with a sodium / hydrogen exchange (NHE) blockers |
| 06/20/2002 | DE10060807A1 Ortho, ortho-substituierte stickstoffhaltige Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen Ortho, ortho-substituted nitrogen-containing Bisarylverbindungen, processes for their preparation, their use as a medicine as well as pharmaceutical compositions containing them |
| 06/20/2002 | DE10060677A1 Klainetine und ihre Derivate, Verfahren zu ihrer Herstellung und Verwendung derselben Klainetins and their derivatives, process for their preparation and use thereof |
| 06/20/2002 | DE10060292A1 Verwendung substituierter Benzimidazole zur Herstellung eines Medikaments zur Behandlung von Krankheiten, welche durch Inhibierung des Na+/H+-Austauschers beeinflusst werden können und sie enthaltendes Medikament Use of substituted benzimidazoles for the manufacture of a medicament for the treatment of diseases which can be influenced by inhibiting the Na + / H + exchanger and containing medicament |
| 06/20/2002 | DE10059418A1 Ortho, meta-substituierte Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen Ortho, meta-substituted Bisarylverbindungen, processes for their preparation, their use as a medicine as well as pharmaceutical compositions containing them |
| 06/20/2002 | CA2445091A1 Pharmaceutical compositions for treatment of digestive disorders and associated diseases |
| 06/20/2002 | CA2432736A1 Silenced anti-cd28 antibodies and use thereof |
| 06/20/2002 | CA2431858A1 Targeted enzymes comprising substrate recognition sites and target binding sites |
| 06/20/2002 | CA2431716A1 Targeted enzyme prodrug therapy |
| 06/20/2002 | CA2431406A1 Quinazolinone derivatives |
| 06/20/2002 | CA2431328A1 14(15)-unsaturated 15- and/or 16- substituted androgens with mixed androgen-progestational profile |
| 06/20/2002 | CA2431326A1 Pyrrolo (2.1-a) dihydroisoquinolines and their use as phosphodiesterase 10a inhibitors |
| 06/20/2002 | CA2431250A1 Composition for regulating animal growth, method of manufacture and use thereof |
| 06/20/2002 | CA2431044A1 Oral compositions and use thereof |
| 06/20/2002 | CA2430992A1 Di-substituted aminomethyl chroman derivative beta-3 adrenoreceptor agonists |
| 06/20/2002 | CA2430906A1 Proteins associated with cell growth, differentiation, and death |
| 06/20/2002 | CA2430905A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/20/2002 | CA2430901A1 Human transporter proteins, nucleic acid molecules encoding them, and uses thereof |
| 06/20/2002 | CA2430760A1 Antilipemic agents |
| 06/20/2002 | CA2430736A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/20/2002 | CA2430458A1 Diaryl peptides as ns3-serine protease inhibitors of hepatits c virus |
| 06/20/2002 | CA2430297A1 Interferon-alpha induced gene |
| 06/20/2002 | CA2430151A1 Phenylacetamido- pyrazole derivatives and their use as antitumor agents |
| 06/20/2002 | CA2429951A1 Antimicrobial quinolones |
| 06/20/2002 | CA2429352A1 Antiviral agents for treatment of flaviviridae infections |
| 06/20/2002 | CA2428216A1 Secreted proteins |
| 06/19/2002 | EP1215587A2 Adenosine monophosphate deaminase crystal structure |
| 06/19/2002 | EP1215497A1 Diagnostics for transmissible spongiform encephalopathy |
| 06/19/2002 | EP1215283A1 NOVEL bHLH TYPE TRANSCRIPTION FACTOR GENE DEC2 |
| 06/19/2002 | EP1215214A1 Novel polypeptide |
| 06/19/2002 | EP1215213A2 Bicyclic amino-pyrazone derivatives, their preparation and pharmaceutical compositions containing them |
| 06/19/2002 | EP1215207A2 Salts of isoleucyl-thiazolidine and -pyrrolidine and their use as dipeptidylpeptidase inhibitors |
| 06/19/2002 | EP1215203A1 Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient |
| 06/19/2002 | EP1214943A1 T-cell therapeutics for transmissible spongiform encephalopathy and method for the manufacture of non-infective blood products and tissue derived products |
| 06/19/2002 | EP1214937A2 Terfenadine carboxylate and the treatment of dermal irritation |
| 06/19/2002 | EP1214936A2 Use of thiazolidin- or pyrrolidin-derivatives of aminoacids as antihyperglycemic agents |
| 06/19/2002 | EP1214927A1 Use of folic acid and/or its derivatives for the manufacture of topical compositions |
| 06/19/2002 | EP1214593A2 Screening for compounds modulating mitochondrial proton leak |
| 06/19/2002 | EP1214589A1 Method and device for detecting and isolating pharmacological compounds being contained in substance mixtures |
| 06/19/2002 | EP1214453A1 Novel cell cycle checkpoint genes and proteins encoded thereby |
| 06/19/2002 | EP1214443A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| 06/19/2002 | EP1214409A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 06/19/2002 | EP1214404A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions |
| 06/19/2002 | EP1214401A2 Dna encoding the human serine protease c-e |